Supply Chain

Eli Lilly (NYSE:LLY) announced today that it plans to build a $5 billion manufacturing facility in Goochland County, Virginia. The new site, just west of Richmond, will be the company’s first dedicated, fully integrated active pharmaceutical ingredient (API) and drug product facility for Lilly’s emerging bioconjugate platform and monocloncal antibody portfolio, according to a news…

Gilead Sciences (Nasdaq:GILD) announced that it broke ground on its new pharmaceutical development and manufacturing (PDM) technical development center (NTDC) in California. The facility, located at the company’s Foster City headquarters, comes as part of a $32 billion investment in U.S. innovation through 2030. Gilead expects the investment to generate more than $43 billion in…

Thermo Fisher Scientific (NYSE:TMO) announced that it completed its acquisition of a Sanofi facility in New Jersey. The company acquired Sanofi’s state-of-the-art sterile fill-finish and packaging site in Ridgefield, New Jersey. In July, the company announced its plans to acquire this site and continue producing a portfolio of Sanofi therapies there while opening the facility…

Optel Group announced that it acquired Vanguard Robotics, an expert in end-of-line collaborative robot (cobot) automation. The acquisition reinforces Optel’s commitment to pharmaceutical automation as a leader in traceability and supply chain solutions. By integrating Vanguard’s robotics technology, Optel believes it can help pharmaceutical manufacturers address labor constraints. It also expects the deal to enhance…

Roche and its Genentech unit today announced the groundbreaking for its newest U.S. manufacturing site in Holly Springs, North Carolina. Genentech said the development marks the establishment of its first manufacturing facility on the East Coast. It designed the 65,000-square-meter facility to support the production of its future portfolio of metabolic medicines. Those include next-generation…

Cambrex announced today that its Snapdragon Chemistry company expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts. The expansion further supports the development and manufacturing of peptide therapies. East Rutherford, New Jersey-based Cambrex said its new GMP manufacturing suite increases the overall facility footprint by 20%. It also includes an ISO-7 cleanroom for preparative…

Bionova Scientific, a subsidiary of Asahi Kasei, today announced the opening of a new plasmid DNA (pDNA) production facility in The Woodlands, Texas. The 10,000-square-foot, state-of-the-art development and production facility sits less than 30 miles north of Houston. It designs, develops and manufactures research-grade pDNA materials to support the cell and gene therapy field. pDNA…

Hikma Pharmaceuticals USA recently announced that it will invest $1 billion by 2030 to further expand U.S. manufacturing and R&D. London-based Hikma has already invested more than $4 billion over the past 15 years in expanding its U.S. presence, which was first established in 1991. The new “America Leans on Hikma” phase, announced June 28,…

Sandoz announced that it began construction on a new, state-of-the-art biosimilars production center in Brnik, Slovenia. The $440 million project enables sterile product manufacturing in the region. It brings the company’s total planned and ongoing investment in Slovenia to more than $1.1 billion by 2029. Sandoz already has ongoing investments there, including a new biosimilar…

Nymi today announced a strategic partnership with Caliber Technologies to accelerate digital transformation in pharmaceutical manufacturing. The partnership aims to enable passwordless authentication on the shop floor. This reduces manual logins and streamlines electronic signatures. Nymi offers the Band biometric, wearable device that authenticates users via fingerprint and facilitates a secure, continuous identity across applications,…